Companies / Brazil
Multinationals Call For Regulatory Reform
September 2006 | Industry NewsResearch-based multinationals in Brazil including US major Merck & Co are calling for thorough reforms to pharmaceutical sector regulation, ahead of the presidential election in October. A key request is greater 'self-regulation' in drug pricing, on the basis that Brazil's consumer price inflation is falling into line with trend levels in many developed
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
